Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia—results of a prospective observational.

Gram-positive infections: lessons learnt and novel solutions

New epidemiology of Staphylococcus aureus infection in Asia

Heterogeneity of disease and clones of community-onset methicillin-resistant Staphylococcus aureus in children attending a paediatric hospital in Belgium

G. Cornaglia, A. Lönnroth, M. Struelens

M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and.

Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus A. Carricajo,

E. Lindberg, I. Adlerberth, A.E. Wold

Clinical impact of antibiotic-resistant Gram-positive pathogens

Cost-effectiveness of universal MRSA screening on admission to surgery

Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality K. Bouiller, H. Gbaguidi-Haore,

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of Spain with a high density of pig farming: a.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? M. Paul, N. Zemer-Wassercug, O.

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 V.

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

Nosocomial infection caused by class 1 integron-carrying Staphylococcus aureus in a hospital in South China Z. Xu, L. Shi, C. Zhang, L. Zhang, X. Li,

Vector control: a cornerstone in the malaria elimination campaign

Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays S. Monecke, R. Ehricht Clinical.

Do we need new antibiotics?

A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V K. Boye, M.D. Bartels, I.S. Andersen, J.A. Møller,

Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci.

Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries A. Deplano, W. Witte, W.J. Van Leeuwen,

The use and therapeutic drug monitoring of teicoplanin in the UK

B. Gordts Clinical Microbiology and Infection

A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia A. Budimir, R.H. Deurenberg, Z. Bošnjak,

Bacterial resistance—the clinical challenge

PCR for the identification of methicillin-resistant Staphylococcus aureus (MRSA) strains using a single primer pair specific for SCCmec elements and the.

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis R. Diaz, V. Afreixo,

Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.

Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals E.E. Udo, N. Al-Sweih, B.

Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.

Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 T. Benfield, F. Espersen,

Abstracts cont. Clinical Microbiology and Infection

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals G.L. Cartolano,

A.W. Karchmer Clinical Microbiology and Infection

P.M. Hawkey Clinical Microbiology and Infection

Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals M.E. Reverdy, S. Jarraud, S. Bohin-Duhreux, E.

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

E. Tacconelli Clinical Microbiology and Infection

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

A. Manzur, F. Gudiol Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

D.A. Robinson, M.C. Enright Clinical Microbiology and Infection

Microarray-based characterisation of a Panton–Valentine leukocidin-positive community- acquired strain of methicillin-resistant Staphylococcus aureus

The first glycopeptide-intermediate Staphylococcus aureus in Oman

The future of diagnostic bacteriology

Presentation transcript:

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis, M.J. Struelens Clinical Microbiology and Infection Volume 11, Issue 3, Pages 214-220 (March 2005) DOI: 10.1111/j.1469-0691.2004.01060.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Vancomycin population analysis of hetero-VISA strains. Clinical Microbiology and Infection 2005 11, 214-220DOI: (10.1111/j.1469-0691.2004.01060.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Teicoplanin population analysis of hetero-VISA strains. Clinical Microbiology and Infection 2005 11, 214-220DOI: (10.1111/j.1469-0691.2004.01060.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions